lexaria bioscienc corp cse lxx otcqx lxrp focu seemingli licens
revenu slow take final report
market data may
see back report rate risk definit
figur us unless otherwis specifi
revenu quarter end februari
reflect yoy declin
revis forecast
million million million
net loss decreas million ep
versu net loss million ep
revis earn forecast million ep
million ep
million ep million ep
compani previous enter
focus invest partnership altria group inc nyse
mo believ poor oper result may indic
compani pivot focus revenu gener
focus focu compani may abl
attract attent larg entiti partner case
altria lead larg potenti licens revenu futur
revis fair valu estim per share
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
compani report revenu reflect yoy revenu declin
six month revenu versu million
reflect yoy declin reason declin revenu
undisclos compani six license account two new license
onboard april may one termin non-
perform one license current gener revenu slow growth
license due delay cannabi edibl infus good legisl within
canada accord manag compani technolog base drug deliveri
applic edibl address market avail domest compani
prior legal infus good smaller would otherwis legal edibl
follow tabl outlin compani oper perform well segment
us ye aug
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
continu under-perform rel revenu forecast minor pace
revenu gener licens would appear lexaria revenu growth prospect
dim revis revenu forecast million
million million respect
us ye aug
long-term revenu forecast also revis lower reflect slower
licens roll-out previous expect mention lexaria need
either sign new licens agreement gener meaning revenu new product
launch ramp sale exist license meet revenu forecast
though revenu forecast continu reduc term coverag
compani specul lack revenu growth may attribut
focu altria inc invest cover previou updat
lexaria incent forego near-term revenu instead focu test
dehydratechtm applic nicotin futur fund altria
specul potenti buy-out depend compani confirm
drug deliveri technolog effect nicotin compani may focus
revenu gener focu ulterior object
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
work
gross margin decreas compar
ebitda increas slightli million versu
million furthermor oper cost drop yoy primarili lower
consult fee million compar million
net loss million ep versu million ep
revis earn forecast million ep
million ep million ep
million ep
lexaria free cash flow neg first six month despit
posit inflow invest activ altria invest
summari flow
effect exchang rate
free flow firm
end compani cash posit million work
capit million well current ratio furthermor compani
remain debt-fre liquid solvenc posit compani like remain
strong given backstop lexaria invest agreement altria detail
outlin previou updat
us ye aug
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
stock option warrant estim compani million stock option
weight averag exercis price million warrant weight averag
exercis price outstand million option million warrant
current in-the-money compani potenti rais million
in-the-money option warrant exercis
maintain buy rate compani revis fair valu
estim lexaria share per share previou fair valu
per share signific drop valu due diminish revenu forecast well
forecast shortfal cash near-term result signific increas share
issu model
believ compani expos follow risk list non-exhaust
possibl inabl appli lexaria deliveri technolog
propos market segment target materi impact compani valuat
lexaria exist patent guarante intern protect
technology- patent relev author need protect
compani technolog jurisdict
cannabi regulatori environ north america exhibit high level
uncertainti open extern interfer beyond lexaria control advers
polit regulatori chang may materi impact compani valuat
compani yet exhibit track record profit despit oper
access capit share dilut
maintain risk rate specul
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
us ye aug
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
